Effect and Tolerance of N5 and N6 Chemotherapy Cycles in Combination with Dinutuximab Beta in Relapsed High-Risk Neuroblastoma Patients Who Failed at Least One Second-Line Therapy.

Holger N. Lode,Ruth Ladenstein,Sascha Troschke-Meurer, Linda Struppe,Nikolai Siebert,Maxi Zumpe,Karoline Ehlert,Stefanie Huber,Evgenia Glogova,Patrick Hundsdoerfer,Angelika Eggert,Anna Zaniewska-Tekieli,Walentyna Balwierz,Aleksandra Wieczorek

Cancers（2023）

引用 0|浏览35

暂无评分

关键词

neuroblastoma,relapsed,refractory,chemoimmunotherapy,ganglioside GD2,dinutuximab beta

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要